This effect was reversed by inhibiting HO activity, not HO-1 protein, by SnMP, a well-known effect for SnMP [37] indicating the pivotal role of HO-1 and HO activity in the regulation of obesity and metabolic syndrome. The gene discussed is HMOX1; the disease is obesity due to melanocortin 4 receptor deficiency.